Browsing by Author Garcia L.

Showing results 1 to 1 of 1
PreviewIssue DateTitleAuthor(s)
14-Jan-2025A phase II study of acimtamig (AFM13) in patients with CD30-positive, relapsed, or refractory peripheral T-cell lymphomas.Kim W.S.; Shortt J. ; Zinzani P.L.; Mikhailova N.; Radeski D.; Ribrag V.; Domenech E.D.; Sawas A.; Alexis K.; Emig M.; Elbadri R.; Hajela P.; Ravenstijn P.; Pinto S.; Garcia L.; Overesch A.; Pietzko K.; Horwitz S.